SCHEMBL6024969

SCHEMBL6024969

CC1(C)C[C@H](N)c2cc(Br)ccc2O1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.37
CTSD P07339 1/20 0.37
KDM1A O60341 3/20 0.36
KDM1B Q8NB78 1/20 0.36
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
TRPV1 Q8NER1 3/20 0.34
HTR2B P41595 3/20 0.33
AHR P35869 1/20 0.33
PBRM1 Q86U86 1/20 0.33
APP P05067 1/20 0.32
AKR1B1 P15121 1/20 0.32
ALDH1A1 P00352 2/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6025054 1.00 BACE1 (0.37) BACE1CTSDKDM1AKDM1BCNR1
SCHEMBL8778940 0.88 CNR1 (0.37) BACE1CTSDCNR1CNR2TRPV1
SCHEMBL15086547 0.87 TRPV1 (0.41) BACE1CTSDKDM1AKDM1BCNR1
SCHEMBL3574214 0.87 TRPV1 (0.41) BACE1CTSDKDM1AKDM1BCNR1
Hydrochloric Acid SCHEMBL6559622 0.87 CNR1 (0.37) BACE1CTSDKDM1ACNR1CNR2
Hydrochloric Acid SCHEMBL23362822 0.86 TRPV1 (0.40) BACE1CTSDKDM1AKDM1BCNR1
SCHEMBL7479500 0.82 HTR2C (0.42) CNR1CNR2HTR2BAKR1B1LMNA
SCHEMBL2177831 0.81 KDM1A (0.35) KDM1AKDM1BTRPV1HTR2BPBRM1
SCHEMBL3322619 0.81 TRPV1 (0.41) KDM1AKDM1BTRPV1AKR1B1
Hydrochloric Acid SCHEMBL6561142 0.81 HTR2C (0.41) CNR1CNR2HTR2BAKR1B1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066379-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME LLC (US) 2025-02-27 US disclosed
WO-2023107356-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME LLC (US) 2023-06-15 WO disclosed
WO-2023102747-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME LLC (US) 2023-06-15 WO disclosed
WO-2023107356-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME LLC (US) 2023-06-15 WO disclosed
EP-1716141-A1 BENZOPYRAN DERIVATIVES, METHOD OF PRODUCTION AND USE THEREOF Université de Liège (BE) 2006-11-02 EP disclosed
WO-2005075463-A1 BENZOPYRAN DERIVATIVES, METHOD OF PRODUCTION AND USE THEREOF UNIVERSITE DE LIEGE (BE) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066379-A1 ANTIMALARIAL AGENTS CTSL, PEPD, SERPINB1 BACE1 1821/4885CTSD 173/4885KDM1A 3694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.